Literature DB >> 3314698

Cefotaxime stability during in vitro microbiological testing.

C R Marchbanks1, R L Yost, R L White.   

Abstract

Cefotaxime is a broad-spectrum cephalosporin which is metabolized or degraded to less active or inactive metabolites by serum esterases, elevated temperatures, or a pH outside of its stability range. Cefotaxime instability during in vitro microbiological susceptibility tests may lead to an underestimation of the antibacterial activity of the compound. Cefotaxime and desacetylcefotaxime solutions were studied under MIC and serum inhibitory titer testing conditions. Cefotaxime concentrations, as measured by high-performance liquid chromatography, decreased 20 to 30% over the incubation period in various systems tested; the greatest decline occurred in systems containing serum in the media. Changes in the results of microbiological susceptibility tests interpreted after 6 and 18 h of incubation were consistent with changes observed in the high-performance liquid chromatography analysis. This study demonstrates cefotaxime instability under conditions of in vitro microbiological testing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314698      PMCID: PMC174945          DOI: 10.1128/AAC.31.9.1375

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Rapid chromatographic determination of cefotaxime and its metabolite in biological fluids.

Authors:  R L Yost; H Derendorf
Journal:  J Chromatogr       Date:  1985-05-31

2.  Metabolism of cefotaxime in animals and man.

Authors:  J Chamberlain; J D Coombes; D Dell; J M Fromson; R J Ings; C M Macdonald; J McEwen
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

4.  Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests.

Authors:  L B Reller; C W Stratton
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

5.  Influence of antibiotic stability on the results of in vitro testing procedures.

Authors:  W E Wick
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

6.  Stability of cefotaxime sodium as determined by high-performance liquid chromatography.

Authors:  V Das Gupta
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

7.  The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.

Authors:  R N Jones; A L Barry; R R Packer
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

8.  In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.

Authors:  K E Aldridge; C V Sanders; R L Marier
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

9.  Metabolism of cefotaxime in animals and humans.

Authors:  J D Coombes
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

10.  Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin.

Authors:  H Fabre; N H Eddine; G Berge
Journal:  J Pharm Sci       Date:  1984-05       Impact factor: 3.534

View more
  5 in total

1.  Effects of supraphysiologic temperature and broth dilution on serum protein binding.

Authors:  R L White; M B Kays; T A Armstrong; L V Friedrich
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.

Authors:  F Vallée; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Use of high-performance liquid chromatography to monitor stability of tetracycline and chlortetracycline in susceptibility determinations.

Authors:  A Ray; V Newton
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

5.  In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations.

Authors:  Elodie A Lallemand; Marlène Z Lacroix; Pierre-Louis Toutain; Séverine Boullier; Aude A Ferran; Alain Bousquet-Melou
Journal:  Front Microbiol       Date:  2016-12-21       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.